Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Eglumegad (LY354740) is a highly potent and selective group II (mGlu2/3) receptor agonist with IC50s of 5 and 24 nM on transfected human mGlu2 and mGlu3 receptors
InChi: InChI=1S/C21H20N2
7-trihydroxy-4-oxo-4H-chromen-8-yl]oxy}-3
Mezerein (50 μg/kg) shows significant inhibitory activity against the P-388 and L-1210 leukemias in mice
ULK-101 is a potent and selective ULK1 inhibitor
Epidermal Growth Factor Receptor Peptide (985-996) Catalog No.:M23036-C Eglumegad (LY354740) is a highlyEGFR (epidermal growth factor receptor) exists on the cell surface and is activated by the binding of its specific ligands, including epidermal growth factor and transforming growth factor . EGFR dimerization stimulates its intrinsic intracellular protein tyrosine kinase activity. As a result, autophosphorylation of several tyrosine (Y) residues on the C terminal domain of EGFR occurs. These include Y992, Y1045, Y1068, Y1148 and Y1173. This
US$ 32.00
US$ 17.00
US$ 25.00
US$ 10.00
US$ 17.00
US$ 25.95
US$ 29.00
US$ 45.00
US$ 25.00